论文信息 - Phase I and pharmacokinetic study of KRN5500, a spicamycin derivative, for patients with advanced solid tumors. - 字舞流文

Phase I and pharmacokinetic study of KRN5500, a spicamycin derivative, for patients with advanced solid tumors.

H. Ono | Y. Tanigawara | Y. Matsumura | Y. Shimada | T. Tamura | K. Shirao | N. Yamamoto | Y. Kamiya | H. Kondoh